Investing in Psychedelic Medicine and Sustainable Solutions for Mental Health and Well Being Mar 2 • 9 min read To learn more about what the fund is building and where it sees the future going in the psychedelic space, we sat down with Noetic’s three managing partners: Michael Franks, Sa’ad Shah and Naseem Saloojee.
TheraPsil Launches Beta Version of Psilocybin Therapy Training Program Mar 2 • 5 min read TheraPsil announced the launch of its Health-Canada-approved, phase 1 psilocybin therapy training program for healthcare professionals.
MindMed Closes Acquisition of HealthMode Mar 1 • 4 min read Mind Medicine (MindMed) Inc. announced that it has closed the previously announced acquisition of HealthMode.
PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange Feb 26 • 3 min read PsyBio Therapeutics Corp. announced that the company will commence trading on the TSX Venture Exchange under the ticker symbol “PSYB”.
PharmaDrug Files For FDA Orphan Drug Designation For DMT Feb 25 • 5 min read PharmaDrug Inc. announced it has expanded its psychedelic pharmaceutical program with the filing of an application with the U.S. Food and Drug Administration.